Ind-Swift Laboratories reports strong half-year revenue, strategic AIF investment

Ind-Swift Laboratories Limited reported its unaudited standalone financial results for the half-year ended September 30, 2025, with revenue from operations reaching ₹29,843.22 Lakhs, up from ₹28,335.83 Lakhs in the previous year. The net profit for the period stood at ₹1,687.63 Lakhs, a decrease from ₹3,885.87 Lakhs in the prior year, primarily due to exceptional items.

The board of directors approved an investment of up to ₹51 Crores in SEBI-registered Alternative Investment Funds (AIFs), to be executed in single or multiple tranches. The board meeting concluded on November 14, 2025.

In other developments, the company noted that the transfer of its Unit IV property in Baddi (H.P.) to the buyer is pending, awaiting certain statutory approvals.